260 related articles for article (PubMed ID: 32132923)
1. Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors.
Escobar ADP; Casanova JP; Andrés ME; Fuentealba JA
Front Pharmacol; 2020; 11():57. PubMed ID: 32132923
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of kappa opioid receptors in the axon initial segment of a group of embryonic mesencephalic dopamine neurons.
Escobar AP; Meza RC; Gonzalez M; Henny P; Andrés ME
IBRO Neurosci Rep; 2022 Jun; 12():411-418. PubMed ID: 35746971
[TBL] [Abstract][Full Text] [Related]
3. Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
Perreault ML; Seeman P; Szechtman H
Behav Neurosci; 2007 Oct; 121(5):976-91. PubMed ID: 17907829
[TBL] [Abstract][Full Text] [Related]
4. Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction.
Karkhanis A; Holleran KM; Jones SR
Int Rev Neurobiol; 2017; 136():53-88. PubMed ID: 29056156
[TBL] [Abstract][Full Text] [Related]
5. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
Acri JB; Thompson AC; Shippenberg T
Synapse; 2001 Mar; 39(4):343-50. PubMed ID: 11169785
[TBL] [Abstract][Full Text] [Related]
6. The blocking of kappa-opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization.
Azocar VH; Sepúlveda G; Ruiz C; Aguilera C; Andrés ME; Fuentealba JA
J Neurochem; 2019 Feb; 148(3):348-358. PubMed ID: 30315655
[TBL] [Abstract][Full Text] [Related]
7. Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors.
Hawes SL; Salinas AG; Lovinger DM; Blackwell KT
J Physiol; 2017 Aug; 595(16):5637-5652. PubMed ID: 28449351
[TBL] [Abstract][Full Text] [Related]
8. κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.
Abraham AD; Fontaine HM; Song AJ; Andrews MM; Baird MA; Kieffer BL; Land BB; Chavkin C
Neuropsychopharmacology; 2018 Jan; 43(2):362-372. PubMed ID: 28649993
[TBL] [Abstract][Full Text] [Related]
9. Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction.
Chartoff EH; Mavrikaki M
Front Neurosci; 2015; 9():466. PubMed ID: 26733781
[TBL] [Abstract][Full Text] [Related]
10. KOR Control over Addiction Processing: An Exploration of the Mesolimbic Dopamine Pathway.
Estave PM; Spodnick MB; Karkhanis AN
Handb Exp Pharmacol; 2022; 271():351-377. PubMed ID: 33301050
[TBL] [Abstract][Full Text] [Related]
11. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
Margolis EB; Hjelmstad GO; Bonci A; Fields HL
J Neurosci; 2003 Nov; 23(31):9981-6. PubMed ID: 14602811
[TBL] [Abstract][Full Text] [Related]
12. Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release.
Chartoff EH; Ebner SR; Sparrow A; Potter D; Baker PM; Ragozzino ME; Roitman MF
Neuropsychopharmacology; 2016 Mar; 41(4):989-1002. PubMed ID: 26239494
[TBL] [Abstract][Full Text] [Related]
13. Repeated administration of the selective kappa-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens.
Fuentealba JA; Gysling K; Magendzo K; Andrés ME
J Neurosci Res; 2006 Aug; 84(2):450-9. PubMed ID: 16676328
[TBL] [Abstract][Full Text] [Related]
14. Voluntary ethanol intake predicts κ-opioid receptor supersensitivity and regionally distinct dopaminergic adaptations in macaques.
Siciliano CA; Calipari ES; Cuzon Carlson VC; Helms CM; Lovinger DM; Grant KA; Jones SR
J Neurosci; 2015 Apr; 35(15):5959-68. PubMed ID: 25878269
[TBL] [Abstract][Full Text] [Related]
15. Reduced dopamine and glutamate neurotransmission in the nucleus accumbens of quinpirole-sensitized rats hints at inhibitory D2 autoreceptor function.
Escobar AP; Cornejo FA; Olivares-Costa M; González M; Fuentealba JA; Gysling K; España RA; Andrés ME
J Neurochem; 2015 Sep; 134(6):1081-90. PubMed ID: 26112331
[TBL] [Abstract][Full Text] [Related]
16. Increased locomotor response to amphetamine induced by the repeated administration of the selective kappa-opioid receptor agonist U-69593.
Fuentealba JA; Gysling K; Andrés ME
Synapse; 2007 Sep; 61(9):771-7. PubMed ID: 17568430
[TBL] [Abstract][Full Text] [Related]
17. Switch from excitatory to inhibitory actions of ethanol on dopamine levels after chronic exposure: Role of kappa opioid receptors.
Karkhanis AN; Huggins KN; Rose JH; Jones SR
Neuropharmacology; 2016 Nov; 110(Pt A):190-197. PubMed ID: 27450094
[TBL] [Abstract][Full Text] [Related]
18. Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine.
Chefer VI; Czyzyk T; Bolan EA; Moron J; Pintar JE; Shippenberg TS
J Neurosci; 2005 May; 25(20):5029-5037. PubMed ID: 15901784
[TBL] [Abstract][Full Text] [Related]
19. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
[TBL] [Abstract][Full Text] [Related]
20. Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats.
Perreault ML; Graham D; Scattolon S; Wang Y; Szechtman H; Foster JA
Psychopharmacology (Berl); 2007 Nov; 194(4):485-96. PubMed ID: 17619861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
